Search over 3,000 reports

    Narcolepsy-Pipeline Insights, 2017

    Narcolepsy-Pipeline Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 78
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIPI0140
    DelveInsight's, "Narcolepsy-Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Narcolepsy. This report provides information on the therapeutic development based on the Narcolepsy dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Pre-Clinical, Discovery and Unknown stages, therapeutics assessment by mono-therapy and combination products and molecule type drug information. The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Narcolepsy - Overview
    Pipeline Therapeutics
    Therapeutics under Development by Companies
    Late Stage Products (Phase III)
    Mid Stage Products (Phase II)
    Early Stage Products (Phase I)
    Pre-Clinical Products
    Discovery Products
    Unknown Phase Products
    Therapeutic Assessment
    Assessment by Mono-therapy Products
    Assessment by Combination Therapy Products
    Assessment by Route of Administration
    Assessment by Stage and Route of Administration
    Assessment by Molecule Type
    Assessment by Stage and Molecule Type
    Dormant Products
    Discontinued Products
    Companies Involved in Therapeutic Development
    Appendix
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1: Number of Products Under Development for Narcolepsy
    Table 2: Number of Products under Development by Companies
    Table 3: Late Stage Products (Phase III)
    Table 4: Mid Stage Products (Phase II)
    Table 5: Early Stage Products (Phase I and IND)
    Table 6: Pre-clinical and discovery Products
    Table 7: Discovery Products
    Table 8: Unknown Phase Products
    Table 9: Assessment by Monotherapy Products
    Table 10: Assessment by Combination Therapy Products
    Table 11: Assessment by Route of Administration
    Table 12:Assessment by Stage and Route Of Administration
    Table 13: Assessment by Molecule Type
    Table 14: Assessment by Stage and Molecule Type
    Table 15: Dormant Products
    Table 16: Discontinued Products
    Table 17: Avadel Pharmaceuticals
    Table 18: Balance Therapeutics Inc.
    Table 19: Heptares Therapeutics Limited
    Table 20: Jazz Pharmaceuticals PLC
    Table 21: NLS Pharma
    Table 22: ONO Pharmaceutical Co. Ltd.
    Table 23: Reset Therapeutics
    Table 24: Taisho Pharmaceutical Co., Ltd.
    Table 25: Theranexus
    Figure 1: Number of Products under Development for Narcolepsy
    Figure 2: Late Stage Products (Phase III)
    Figure 3: Mid Stage Products (Phase II)
    Figure 4: Early Stage Products (Phase I)
    Figure 5: Pre-clinical and discovery Products
    Figure 6: Discovery Products
    Figure 7: Unknown Phase Products
    Figure 8: Assessment by Mono-therapy Products
    Figure 9: Assessment by Combination Therapy Products
    Figure 10: Assessment by Route of Administration
    Figure 11: Assessment by Stage and Route of Administration
    Figure 12: Assessment by Molecule Type
    Figure 13: Assessment by Stage and Molecule Type
    Figure 14: Dormant Products
    Figure 15: Discontinued Products
    Narcolepsy Pipeline Drugs

    Narcolepsy Pipeline Assessment

    Narcolepsy Pipeline Analysis

    Narcolepsy Drugs under Development

    Narcolepsy Discovery drugs

    Narcolepsy Preclinical drugs

    Narcolepsy Phase I drugs

    Narcolepsy Phase II drugs

    Narcolepsy Phase III Pipeline Drugs Assessment

    Narcolepsy Preregistration drugs

    Narcolepsy Molecules in pipeline

    • Single User License
      (20% Off)
      $1,250.00
    • Site License
      (30% Off)
      $2,500.00
    • Global License
      (40% Off)
      $4,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap